Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue

Shu Q. Liu*, Derek Roberts, Alexei Kharitonenkov, Brian Zhang, Samuel M. Hanson, Yan Chun Li, Li Qun Zhang, Yu H. Wu

*Corresponding author for this work

Research output: Contribution to journalArticle

86 Scopus citations

Abstract

Myocardial ischemia, while causing cardiomyocyte injury, can activate innate protective processes, enhancing myocardial tolerance to ischemia. Such processes are present in not only the heart, but also remote organs. In this investigation, we demonstrated a cardioprotective process involving FGF21 from the liver and adipose tissue. In response to myocardial ischemia/reperfusion injury in the mouse, FGF21 was upregulated and released from the hepatic cells and adipocytes into the circulation and interacted with FGFR1 in cardiomyocytes under the mediation of the cell membrane protein β-Klotho, inducing FGFR1 phosphorylation. This action caused phosphorylation of the signaling molecules PI3K p85, Akt1, and BAD, thereby reducing caspase 3 activity, cell death, and myocardial infarction in association with improvement of myocardial function. These observations suggest that FGF21 is upregulated and released from the liver and adipose tissue in myocardial injury, contributing to myocardial protection by the mediation of the FGFR1/β-Klotho-PI3K-Akt1-BAD signaling network.

Original languageEnglish (US)
Article number2767
JournalScientific reports
Volume3
DOIs
StatePublished - Oct 14 2013

    Fingerprint

ASJC Scopus subject areas

  • General

Cite this

Liu, S. Q., Roberts, D., Kharitonenkov, A., Zhang, B., Hanson, S. M., Li, Y. C., Zhang, L. Q., & Wu, Y. H. (2013). Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue. Scientific reports, 3, [2767]. https://doi.org/10.1038/srep02767